CLINICAL_TRIALS
trial_result
· 2016-08-16
Clinical Trial Update: Leptin to Treat Lipodystrophy [Phase 2]
Summary
Phase 2 trial results for metreleptin (leptin) in lipodystrophy have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Lipodystrophy | Phase 2 | Status: COMPLETED | Results posted: 2016-08-16